Cargando...
Non-vitamin K antagonist oral anticoagulants in cancer patients with atrial fibrillation
To the best of our knowledge, non-vitamin K antagonist oral anticoagulants (NOACs), or direct oral anticoagulants, have not been tested in randomized trials conducted in patients with atrial fibrillation (AF), affected by malignant disease. However, their use in patients with cancer is increasing, w...
Guardado en:
| Publicado en: | Anatol J Cardiol |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Kare Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7141434/ https://ncbi.nlm.nih.gov/pubmed/31911561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14744/AnatolJCardiol.2019.30766 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|